Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of CD3+ and NKp46+ Cells in Resected Colorectal Liver Metastases.

NCT02615665 is registered in ClinicalTrials.gov with University of Milan as lead sponsor.

NCT NCT02615665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02615665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of CD3+ and NKp46+ Cells in Resected Colorectal Liver Metastases.
Lead sponsor
University of Milan
Phase
Observational
Overall status
Completed
Start date
January 31, 2013
Completion date
August 31, 2015
Enrollment
121 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal liver metastases